Picture of Core Laboratories logo

CLB Core Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
IndustrialsAdventurousMid CapNeutral

Core Laboratories Inc reports results for the quarter ended December 31 - Earnings Summary

* Core Laboratories Inc  CLB.N  reported quarterly adjusted
earnings of 22 cents​​ per share for the quarter ended December
31, higher than the same quarter last year, when the company
reported EPS of 19 cents.  The mean expectation of five analysts
for the quarter was for earnings of 22 cents per share. Wall
Street expected results to range from 19 cents to 23 cents per
share.
    * Revenue rose 0.8% to $129.24 million from a year ago;
analysts
expected $132.44 million. 
    * Core Laboratories Inc's reported EPS for the quarter was
15
cents​.
    * The company reported quarterly net income of $7.4 million.
    * Core Laboratories Inc shares had risen by 7.1% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.6%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and 2 "sell" or "strong sell." 
    * The average consensus recommendation for the business
support
services peer group is also "hold"

Wall Street's median 12-month price target for Core Laboratories
Inc is $19.00 
This summary was machine generated from LSEG data January 30 at
01:05 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2024      0.22           0.22           Met
 Sep. 30 2024      0.23           0.25           Beat
 Jun. 30 2024      0.21           0.22           Beat
 Mar. 31 2024      0.16           0.19           Beat

Recent news on Core Laboratories

See all news